The PD-1/PD-L1 signaling pathway has been used by microorganisms and tumor cells to decrease host immune system activity, permitting chronic infection, cell transformation into the tumor, and tumor cell survival (Ishida et al., 1992; Keir et al., 2008). Here, PDCD1 is linked to neoplasm.